Product Program year 2022 Source: CMS Open Payments

Tauvid

Drug Neuroscience

NDC 0002-1210-30

Open in the dashboard

General payments

$534

11 payments

Research payments

$0

0 payments

Through program year 2022, $534 in general payments and $0 in research payments were reported against Tauvid (Neuroscience).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2022 General $517 10
2020 General $16 1

Breakdown

Who paid General payments · program years 2020–2022
  1. Lilly USA, LLC $534 11 payments
Top recipients General payments · program year 2022
  1. David Hunter Behavioral Neurology & Neuropsychiatry · Houston, TX $79 15% · 1 payment
  2. Paul Schulz Behavioral Neurology & Neuropsychiatry · Houston, TX $79 15% · 1 payment
  3. Amanda Falk Vargas Nurse Practitioner, Family · Houston, TX $79 15% · 1 payment
  4. Carlos Julian Martinez-Menendez Neurology · Harlingen, TX $79 15% · 1 payment
  5. Fawad Khan Clinical Neurophysiology · New Orleans, LA $75 15% · 1 payment

The top 5 of 10 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Neurology Psychiatry & Neurology $185 36% · 5 practitioners
  2. Behavioral Neurology & Neuropsychiatry Psychiatry & Neurology $158 31% · 2 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $79 15% · 1 practitioner
  4. Clinical Neurophysiology Psychiatry & Neurology $75 15% · 1 practitioner
  5. Physician Assistant $20 4% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2022
  1. Texas $442 85% · 9 recipients
  2. Louisiana $75 15% · 1 recipient

Each share is of general payments naming this product in 2022 where a state was reported.

11 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record